Stevanato Group S.p.A.
Stevanato is shifting toward higher-value pharmaceutical containment and drug-delivery products, particularly for biologic treatments and GLP-1 medicines. High-value solutions…
STVN
2 published ideas on Stevanato Group S.p.A. across 2 funds — 2 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Stevanato Group S.p.A.: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Stevanato is shifting toward higher-value pharmaceutical containment and drug-delivery products, particularly for biologic treatments and GLP-1 medicines. High-value solutions…
Stevanato is an existing Reversionary investment that Cooper believes is approaching a cash-flow inflection. The pharmaceutical-glass manufacturer is nearing completion of a…